Tanvex BioPharma Inc
TWSE:6541
Tanvex BioPharma Inc
TWSE:6541
Price:
44.8
TWD
0.45%
Market Closed
Market Cap:
NT$11.9B
Income Statement
Earnings Waterfall
Tanvex BioPharma Inc
Tanvex BioPharma Inc
Income Statement
Tanvex BioPharma Inc
Tanvex BioPharma Inc
Currency: TWD
| Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
8
|
12
|
16
|
15
|
14
|
14
|
19
|
26
|
33
|
42
|
46
|
49
|
51
|
54
|
55
|
55
|
55
|
55
|
57
|
59
|
59
|
58
|
53
|
52
|
49
|
48
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+87%
|
5
+862%
|
9
+58%
|
12
+36%
|
19
+67%
|
22
+16%
|
49
+121%
|
63
+28%
|
60
-5%
|
61
+2%
|
35
-44%
|
35
0%
|
41
+19%
|
35
-15%
|
81
+134%
|
111
+37%
|
225
+103%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(23)
|
(25)
|
(33)
|
(42)
|
(10)
|
(14)
|
(7)
|
(2)
|
(15)
|
(26)
|
(30)
|
(26)
|
(95)
|
(138)
|
(420)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+80%
|
4
+1 276%
|
(14)
N/A
|
(14)
+5%
|
(13)
+4%
|
(19)
-46%
|
39
N/A
|
50
+26%
|
53
+7%
|
60
+13%
|
20
-67%
|
8
-58%
|
11
+30%
|
8
-24%
|
(14)
N/A
|
(27)
-85%
|
(196)
-635%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(1 352)
|
(1 445)
|
(1 496)
|
(1 493)
|
(1 403)
|
(1 416)
|
(1 717)
|
(1 893)
|
(1 951)
|
(2 149)
|
(2 043)
|
(2 257)
|
(2 328)
|
(2 416)
|
(2 429)
|
(2 183)
|
(2 100)
|
(1 890)
|
(1 787)
|
(1 723)
|
(1 603)
|
(1 503)
|
(1 461)
|
(1 465)
|
(1 586)
|
(1 913)
|
(2 006)
|
(2 126)
|
(2 160)
|
(1 951)
|
(1 802)
|
(1 592)
|
(1 365)
|
(1 329)
|
(1 273)
|
(1 145)
|
|
| Selling, General & Administrative |
(242)
|
(266)
|
(279)
|
(306)
|
(316)
|
(325)
|
(333)
|
(327)
|
(296)
|
(302)
|
(313)
|
(317)
|
(327)
|
(312)
|
(265)
|
(249)
|
(238)
|
(225)
|
(237)
|
(224)
|
(219)
|
(199)
|
(208)
|
(213)
|
(235)
|
(326)
|
(365)
|
(403)
|
(454)
|
(385)
|
(367)
|
(342)
|
(307)
|
(362)
|
(357)
|
(380)
|
|
| Research & Development |
(1 097)
|
(1 166)
|
(1 203)
|
(1 172)
|
(1 073)
|
(1 046)
|
(1 340)
|
(1 523)
|
(1 644)
|
(1 838)
|
(1 722)
|
(1 933)
|
(1 995)
|
(2 098)
|
(2 158)
|
(1 929)
|
(1 857)
|
(1 259)
|
(1 146)
|
(1 094)
|
(1 382)
|
(1 302)
|
(1 252)
|
(1 250)
|
(1 350)
|
(1 586)
|
(1 640)
|
(1 721)
|
(1 706)
|
(1 557)
|
(1 426)
|
(1 241)
|
(1 057)
|
(956)
|
(894)
|
(683)
|
|
| Depreciation & Amortization |
(13)
|
(13)
|
(14)
|
(15)
|
(15)
|
(14)
|
(13)
|
(12)
|
(10)
|
(9)
|
(8)
|
(7)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
(4)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(11)
|
(24)
|
(33)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
(31)
|
(31)
|
(31)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(401)
|
(401)
|
(401)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(8)
|
(8)
|
0
|
0
|
0
|
(49)
|
|
| Operating Income |
(1 352)
N/A
|
(1 445)
-7%
|
(1 496)
-3%
|
(1 493)
+0%
|
(1 403)
+6%
|
(1 416)
-1%
|
(1 717)
-21%
|
(1 893)
-10%
|
(1 951)
-3%
|
(2 149)
-10%
|
(2 043)
+5%
|
(2 257)
-11%
|
(2 328)
-3%
|
(2 416)
-4%
|
(2 429)
-1%
|
(2 183)
+10%
|
(2 100)
+4%
|
(1 889)
+10%
|
(1 787)
+5%
|
(1 723)
+4%
|
(1 599)
+7%
|
(1 517)
+5%
|
(1 475)
+3%
|
(1 478)
0%
|
(1 606)
-9%
|
(1 874)
-17%
|
(1 957)
-4%
|
(2 073)
-6%
|
(2 101)
-1%
|
(1 932)
+8%
|
(1 794)
+7%
|
(1 580)
+12%
|
(1 357)
+14%
|
(1 343)
+1%
|
(1 299)
+3%
|
(1 341)
-3%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
95
|
(0)
|
19
|
24
|
29
|
33
|
41
|
47
|
57
|
67
|
69
|
70
|
53
|
41
|
25
|
12
|
(6)
|
(15)
|
(25)
|
(33)
|
(36)
|
(34)
|
(35)
|
(35)
|
(33)
|
(41)
|
(35)
|
(22)
|
(27)
|
(14)
|
(13)
|
(20)
|
(5)
|
(13)
|
(83)
|
(86)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
0
|
(49)
|
(49)
|
0
|
|
| Gain/Loss on Disposition of Assets |
(3)
|
(1)
|
0
|
(1)
|
(5)
|
(6)
|
(6)
|
(5)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(1)
|
(1)
|
0
|
(5)
|
(7)
|
0
|
(8)
|
(4)
|
(3)
|
(3)
|
(2)
|
0
|
0
|
(6)
|
(7)
|
15
|
|
| Total Other Income |
15
|
15
|
14
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
93
|
93
|
93
|
92
|
2
|
4
|
4
|
(3)
|
4
|
3
|
3
|
2
|
1
|
(18)
|
(19)
|
(20)
|
33
|
51
|
|
| Pre-Tax Income |
(1 244)
N/A
|
(1 432)
-15%
|
(1 462)
-2%
|
(1 469)
-1%
|
(1 410)
+4%
|
(1 389)
+1%
|
(1 681)
-21%
|
(1 850)
-10%
|
(1 894)
-2%
|
(2 081)
-10%
|
(1 973)
+5%
|
(2 187)
-11%
|
(2 274)
-4%
|
(2 374)
-4%
|
(2 403)
-1%
|
(2 170)
+10%
|
(2 104)
+3%
|
(1 903)
+10%
|
(1 720)
+10%
|
(1 663)
+3%
|
(1 543)
+7%
|
(1 460)
+5%
|
(1 508)
-3%
|
(1 514)
0%
|
(1 641)
-8%
|
(1 917)
-17%
|
(1 996)
-4%
|
(2 097)
-5%
|
(2 137)
-2%
|
(1 946)
+9%
|
(1 807)
+7%
|
(1 620)
+10%
|
(1 381)
+15%
|
(1 431)
-4%
|
(1 405)
+2%
|
(1 361)
+3%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(1)
|
(0)
|
(0)
|
3
|
3
|
3
|
|
| Income from Continuing Operations |
(1 244)
|
(1 432)
|
(1 462)
|
(1 469)
|
(1 410)
|
(1 389)
|
(1 681)
|
(1 850)
|
(1 894)
|
(2 081)
|
(1 974)
|
(2 187)
|
(2 274)
|
(2 374)
|
(2 403)
|
(2 170)
|
(2 104)
|
(1 903)
|
(1 720)
|
(1 663)
|
(1 543)
|
(1 460)
|
(1 508)
|
(1 514)
|
(1 641)
|
(1 917)
|
(1 996)
|
(2 097)
|
(2 137)
|
(1 947)
|
(1 808)
|
(1 621)
|
(1 382)
|
(1 429)
|
(1 402)
|
(1 358)
|
|
| Net Income (Common) |
(1 244)
N/A
|
(1 432)
-15%
|
(1 462)
-2%
|
(1 469)
-1%
|
(1 410)
+4%
|
(1 389)
+1%
|
(1 681)
-21%
|
(1 850)
-10%
|
(1 894)
-2%
|
(2 081)
-10%
|
(1 974)
+5%
|
(2 187)
-11%
|
(2 274)
-4%
|
(2 374)
-4%
|
(2 403)
-1%
|
(2 170)
+10%
|
(2 104)
+3%
|
(1 903)
+10%
|
(1 720)
+10%
|
(1 663)
+3%
|
(1 543)
+7%
|
(1 460)
+5%
|
(1 508)
-3%
|
(1 514)
0%
|
(1 641)
-8%
|
(1 917)
-17%
|
(1 996)
-4%
|
(2 097)
-5%
|
(2 137)
-2%
|
(1 947)
+9%
|
(1 808)
+7%
|
(1 621)
+10%
|
(1 382)
+15%
|
(1 429)
-3%
|
(1 402)
+2%
|
(1 358)
+3%
|
|
| EPS (Diluted) |
-6.25
N/A
|
-7.27
-16%
|
-7.42
-2%
|
-7.44
0%
|
-6.9
+7%
|
-6.28
+9%
|
-7.6
-21%
|
-7.84
-3%
|
-7.45
+5%
|
-8.48
-14%
|
-8.02
+5%
|
-8.67
-8%
|
-8.93
-3%
|
-8.76
+2%
|
-8.86
-1%
|
-8.21
+7%
|
-22.42
-173%
|
-5.96
+73%
|
-5.38
+10%
|
-5.1
+5%
|
-13.71
-169%
|
-4.14
+70%
|
-4.27
-3%
|
-12.55
-194%
|
-13.32
-6%
|
-16.29
-22%
|
-15.16
+7%
|
-15.5
-2%
|
-16.23
-5%
|
-14.52
+11%
|
-11.37
+22%
|
-9.76
+14%
|
-8.81
+10%
|
-6.35
+28%
|
-5.87
+8%
|
-5.36
+9%
|
|
Switch to:
Switch to:
See Also
Discover More
